FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT)

Historical Holders from Q1 2014 to Q1 2025

Symbol
FBT
CUSIP
33733E203
Type / Class
Equity / NY ARCA BIOTECH
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
3.42M
Holdings value
$569M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
250
Number of buys
99
Number of sells
-106
Average Value change %
-0.01%
Average buys %
+0%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 268K $45.4M -$2.7M $170.12 64
2024 Q4 3.42M $569M +$43M $166.21 250
2024 Q3 3.14M $539M -$51.2M $171.93 251
2024 Q2 3.46M $533M -$21.7M $153.99 246
2024 Q1 3.4M $523M -$58.3M $153.77 240
2023 Q4 3.31M $522M -$107M $158.06 250
2023 Q3 4.18M $612M -$63.9M $146.35 236
2023 Q2 4.61M $706M -$20.4M $153.14 245
2023 Q1 4.69M $727M -$18.4M $155.03 239
2022 Q4 4.87M $750M +$55.4M $154.13 235
2022 Q3 4.48M $592M +$21.6M $131.98 207
2022 Q2 4.31M $585M -$26.9M $135.56 213
2022 Q1 4.34M $648M -$78.4M $149.14 207
2021 Q4 4.95M $801M -$47.4M $161.96 237
2021 Q3 5.18M $860M -$14.1M $166.06 230
2021 Q2 5.22M $900M -$80.5M $172.62 226
2021 Q1 5.72M $919M -$20.3M $160.50 230
2020 Q4 5.81M $976M -$78.2M $167.99 229
2020 Q3 6.09M $959M -$32.9M $157.26 208
2020 Q2 6.23M $1.05B +$186M $167.77 221
2020 Q1 4.99M $654M -$51M $131.12 189
2019 Q4 4.68M $696M -$70.7M $148.72 202
2019 Q3 5.2M $645M -$826M $123.76 183
2019 Q2 12.6M $1.77B +$31.7M $140.84 215
2019 Q1 12.4M $1.86B +$134M $150.85 223
2018 Q4 11.6M $1.44B -$403M $124.20 188
2018 Q3 14.2M $2.25B +$1.43B $158.49 187
2018 Q2 5.13M $719M +$65.2M $140.01 153
2018 Q1 4.67M $620M +$88.5M $132.90 150
2017 Q4 3.98M $496M +$54.5M $124.57 125
2017 Q3 3.61M $447M +$13.8M $123.93 114
2017 Q2 3.49M $398M +$54.6M $114.04 111
2017 Q1 3.02M $317M -$6.54M $105.30 112
2016 Q4 3.1M $282M +$13M $90.87 106
2016 Q3 2.91M $289M -$409K $99.71 109
2016 Q2 3.08M $275M -$39.5M $89.43 105
2016 Q1 3.32M $292M -$1.88B $87.56 101
2015 Q4 21.8M $2.46B +$164M $113.02 126
2015 Q3 20.1M $2.04B +$162M $101.32 126
2015 Q2 18.5M $2.29B +$283M $124.02 122
2015 Q1 16.1M $1.91B +$448M $118.23 118
2014 Q4 12.3M $1.26B +$246M $102.02 108
2014 Q3 9.63M $884M +$85.6M $91.78 95
2014 Q2 8.69M $716M +$32.2M $82.33 91
2014 Q1 8.32M $638M +$51.7M $76.69 81